Test: Biontech Vaccine Helps Against Mutations
There is great concern that mutated coronaviruses will continue to spread. Do the previously approved vaccines also help against the new variants? At least in the case of Biontech and Pfizer, according to a study provides the first encouraging results is as expected
The vaccine from partners Biontech and Pfizer appear to be effective against the virus variants discovered in Great Britain and South Africa, according to a study carried out by the US drug manufacturer. “We’ve now tested 16 different mutations, none of which had any really significant effects. That’s the good news,” says one of Pfizer’s leading viral vaccine scientists. “But that doesn’t mean the 17th won’t have any impact.” The study by Pfizer and scientists from the Medical Department of the University of Texas, which has not yet been peer-reviewed, shows that the vaccine was effective in neutralizing the virus even if the so-called spike protein was changed.
A mutated variant of the coronavirus is detected in Saxony
A mutated variant of the coronavirus is also rampant in Germany. It was last detected in Saxony. According to the Ministry of Health in Dresden, the virus mutation occurred in a person from Dresden who had returned from Great Britain. For the first time, the corona mutation from England was detected in Germany on Christmas Eve. A woman in Baden-Württemberg who had come from Great Britain was affected. According to scientists, the variant is significantly more contagious than the previously known version.
Sahin: ” The vaccine will also help against the mutation”
Biontech boss Ugur Sahin also assumes that the vaccine will also help against the mutation. In addition, the existing vaccine could be “reworked” within six weeks and tailored specifically to the mutation, Sahin said.
Meanwhile, the federal states expect a new vaccine delivery from Biontech in the course of the day. They should get a total of almost 668,000 vaccination doses. The delivery should go directly from the manufacturer to the 27 delivery centers in the countries. The most populous state of North Rhine-Westphalia receives the largest share with 141,375 cans. Bremen gets the smallest share with 4875 cans. The delivery was announced on this scale. Since the start of the vaccination campaign at the end of December, at least 417,060 people in Germany have been injected, as the Robert Koch Institute ( RKI ) announced on Thursday.
Test: Biontech Vaccine Helps Against Mutations
You may also like:
